Skip to main content
. 2015 Mar 27;4:6. doi: 10.1186/s40035-015-0027-z

Table 1.

Demographic and clinical characteristics of VBM studies for GMV on AD in meta-analysis

Study Number Age Education MMSE Diagnostic criteria
(Female) (Years) (Years)
AD NC AD NC AD NC AD NC
Guo2014 [11] 35 (23) 27 (11) 72.4 (8.5) 69.2 (6.5) NA NA 19.7 (4.1) 28.9 (1.0) ICD-10 criteria
Teipel2012 [30] 137 (79) 143 (72) 72.5 (8.3) 69.2 (5.9) 10.2 (3.3) 13.1 (3.8) 20.6 (5.3) 28.8 (1.1) NINCDS-ADRDA
Rami2012 [12,62] 32 24 75.5 (5.5) 71.4 (6.6) 8.3 (2.9) 9.0 (4.7) 22.5 (3.3) 28.1 (1.4) NINCDS-ADRDA
Gili2011 [29] 11 (4) 10 (3) 71.9 (7.9) 64.1 (10.5) 9.9 (4.9) 14.3 (3.4) 19.7 (4.5) 28.34 (2.0) NINCDS-ADRDA
Lehmann2011 [13] 30 (16) 50 (33) 69.2 (8.9) 63.7 (9.6) NA NA NA NA NINCDS-ADRDA
Serra2010 [14] 9 (6) 13 (4) 72.4 (7.5) 64.1 (10.5) 9.9 (4.9) 14.3 (3.4) 18.2 (4.4) 28.9 (1.3) NINCDS-ADRDA
Guo2010 [23] 13 (7) 14 (8) 72.1 (6.5) 70.4 (3.5) NA NA 18.5 (3.5) 28.5 (0.6) NINCDS-ADRDA
Ibrahim2009 [22] 20 (11) 23 (18) 73.67 (7.58) 66.70 (5.82) 13.10 (2.95) 14.22 (2.36) 15.60 (7.20) 29.13 (0.99) NINCDS-ADRDA
Kanda2008 [15] 20 20 65.0 65.2 NA NA 17.5 29.0 NINCDS-ADRDA
Whitwell2007 [5,16] 38 (22) 38 (22) 65.3 (6.9) 65.9 (7.0) 12.5 14.0 17.0 29.0 NINCDS-ADRDA
Hamalainen2007 [24] 15 (10) 21 (17) 73.1 (6.7) 71.2 (4.9) 8.2 (2.7) 7.9 (2.9) 21.7 (3.7) 27.7 (2.0) NINCDS-ADRDA
DiPaola2007 [18] 18 (14) 18 (14) 64.3 (10.2) 65.4 (10.6) 8.8 (4.2) 8.1 (2.8) 16.9 (4.3) 29.0 (1.6) NINCDS-ADRDA
Samuraki2007 [28] 39 (20) 73 (36) 68.03 (8.76) 66.78 (8.34) NA NA 22.3 (3.3) 29.2 (0.8) NINCDS-ADRDA
Rabinovici2007 [17] 11 (6) 40 (23) 64.5 (9.7) 63.5 (5.8) 16.5 (2.9) 17.4 (2.4) 19.9 (6.9) 29.7 (0.5) NINCDS-ADRDA
Bozzali2006 [26] 22 (11) 20 (13) 67.9 (7.6) 65.8 (6.8) NA NA 19.8 (4.1) 27.3 (1.2) NINCDS-ADRDA
Shiino2006 [27] 40 (21) 88 (48) 71.1 (9.7) 68.7 (8.7) NA NA 18.03 (3.91) 29.09 (1.47) NINCDS-ADRDA
Ishii2005 [19] 30 (22) 30 (22) 66.8 (7.0) 66.8 (7.9) NA NA 14.7 (5.4) 24.0 (2.2) NINCDS-ADRDA
Hirata2005 [7] 61 (29) 82 (43) 70.6 (8.4) 70.1 (7.7) NA NA 26.0 (1.5) 28.7 (1.5) NINCDS-ADRDA
Boxer2003 [20] 11 (8) 15 (7) 69.6 (8.2) 65.1 (8.3) 16.3 (3.8) 16.6 (3.9) 20.2 (7.3) 29.5 (0.5) NINCDS-ADRDA
Frisoni2002 [21] 29 (23) 26 (17) 74 (9) 69 (8) 7 (4) 8 (3) 21 (4) 29 (1) NINCDS-ADRDA
Ohnishi2001 [25] 26 (15) 47 (16) 72.1 (1.1) 28.5 (6.0) NA NA 20.7 (3.1) NA NINCDS-ADRDA
Matsuda2002 [34] 15 (4) 25 (9) 71.1 (7.1) 71.2 (7.3) NA NA 21.5 (2.9) 29.5 (0.6) DSM-IV
Busatto2003 [35] 14 (5) 14 (6) 72.2 (7.2) 69.4 (5.9) 9.1 (4.2) 7.1 (4.7) 20.7 (3.1) 29.1 (0.5) NINCDS-ADRDA
Raji2009 [31] 33 (20) 169 (96) 82.8 (5.16) 77.57 (3.62) NA NA NA NA NINCDS-ADRDA
Honea2009 [32] 61 (37) 56 (33) 74.3 (6.3) 73.3 (6.2) 15.3 (3.3) 16.4 (2.2) 26.2 (3.7) 29.4 (0.8) NINCDS-ADRDA
Brenneis2004 [36] 10 (3) 10 (6) 73.1 (7.6) 65.1 (8.1) NA NA 17.4 (7.9) 28.8 (1.6) DSM-IV
Hirao2006 [39] 61 (29) 61 (31) 70.6 (8.4) 70.2 (7.3) NA NA 26.0 (1.5) 28.7 (1.5) NINCDS-ADRDA
Brambati2009 [33] 10 (5) 13 (8) 71.5 (5.9) 75.0 (5.0) 12.6 (4.7) 14.9 (5.0) 22.5 (2.3) 29.1 (1.2) NINCDS-ADRDA
Baxter2006 [38] 15 (4) 15 (8) 75.5 (7.8) 76.4 (7.9) 14.7 (2.9) 15.3 (2.9) 14–28 28.5 (1.1) NINCDS-ADRDA
Zahn2005 [37] 10 (6) 10 (5) 66.5 (8.9) 65.8 (7.8) NA NA 23.6 (2.8) NA NINCDS-ADRDA

Key: AD, Alzheimer’s disease; NC, normal cognition subjects; MMSE, the Mini Mental State Examination; NA, not available; VBM, voxel-based morphometry; GMV, Grey matter volume; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke/Alzheimer’s Disease and Related Disorders Association; DSM, Diagnostic and Statistical Manual of Mental Disorders; ICD-10 criteria, International Classification of Diseases, 10th Revision.